Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Stomach Neoplasms 38Pancreatic Neoplasms 11Esophageal Neoplasms 8Biliary Tract Neoplasms 8Colorectal Neoplasms 7Neoplasm Metastasis 3Gastrointestinal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumors 3Neoplasms 2Head and Neck Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2Advanced Non-Small Cell Lung Cancer 2Advanced Gastric Cancer 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Progression Free Survival 1Patients With Advanced or Metastatic Solid Tumors 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Overall Survival 1Nasopharyngeal Carcinoma 1Hand-Foot Syndrome 1Carcinoma, Transitional Cell 1Breast Neoplasms 1Advanced Pancreatic Cancer 1Adenocarcinoma Of Esophagus 1

Interventions

S 1 (combination) 2Gemcitabine 2lorlatinib 1Erlotinib Hydrochloride 1Docetaxel 1Cisplatin 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Advanced Non-Small Cell Lung Cancer × S 1 (combination) × Clear all
NCT00651833 2024-09-03

Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer

Taiho Oncology, Inc.

Phase 2 Completed
60 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

NCT00652561 2024-09-03

Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung Cancer

Taiho Oncology, Inc.

Phase 2 Completed
57 enrolled
Thoracic

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡